UNSPSC 85811004: Introduction of liquid brachytherapy radioisotope into peritoneal cavity, via natural or artificial opening

This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of liquid brachytherapy radioisotope into peritoneal cavity, via natural or artificial opening. This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E0M704

UNSPSC 85811004, Introduction of liquid brachytherapy radioisotope into peritoneal cavity via natural or artificial opening, is a Commodity code that shows no substantive recent state and local procurement activity aligned with its nominal scope. The recent opportunities tagged to this code cover virtual urgent care, medical services, PACE operations, occupational health, cancer screening, employee wellness, student support services, behavioral health, and various clinical staffing and facility services—none of which involve brachytherapy or radioisotope administration.

The source records indicate a systematic mismatch between the code assignment and actual procurement content. State and local agencies across California (Inland Empire Health Plan, San Mateo County), Georgia (DeKalb County), Nevada (Nevada Health Authority), Colorado (Department of Human Services), Kansas (Sedgwick County and City of Wichita), Florida (Sarasota County, Seminole County, City of Ocala, City of Phoenix), Texas (HHSC, Jackson County), and other jurisdictions are actively soliciting primary care, urgent care, mental health, substance use disorder treatment, occupational health, dental, vision, cancer registry, and emergency medical services. Issuing bodies span state departments, county health authorities, municipalities, and regional health systems. None of the recent activity reflects the specialized oncology or interventional radiology service the code nominally describes. If your firm has capability in brachytherapy or radioisotope-based cancer treatment delivery to state and local healthcare systems, this code shows insufficient recent procurement signal to justify active pursuit; monitor the code for future activity or verify code assignment with issuing agencies before investing qualification effort.